Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAT STUDY: Focalin XR vs Adderall XR in ADHD
NCT00393042Phase 3Completed
- Sponsor
- Seattle Children's
- Start
- Jan 2006
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmethylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Seattle Children's. Primary endpoints: Sleep Start Time, Sleep End Time and 1 more. Started Jan 2006; status: completed.
02
Drugs
dexmethylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00393042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00393042.